The National Institutes of Health (NIH), through the participating
Institutes, Centers, and Offices listed above, invite applications for
infrastructure grants in support of research on mind-body interactions
and health. "Mind-body interactions and health" refers to the
relationships among cognitions, emotions, personality, social
relationships, and health. Applicant institutions may request funds to
support infrastructure and research designed to (1) enhance the quality
and quantity of mind-body and health research and (2) develop new
research capabilities to advance mind-body and health research through
innovative approaches. These activities must reflect a research theme
that is driven by scientific questions within the context of "Mind-body
interactions and health" research. A central goal of this program is to
facilitate interdisciplinary collaboration and innovation in mind-body
and health research while providing essential and cost-effective core
services in support of the development, conduct, and translation into
practice of mind-body and health research based in centers or comparable
administrative units.
This announcement invites applications for R21 EXPLORATORY/DEVELOPMENTAL
AWARDS. Exploratory/Developmental Awards are intended to support the
development and demonstrate the feasibility of programs at institutions
that have high potential for advancing mind-body and health research,
but have not yet fully achieved the necessary resources and mechanisms
to qualify for a R24 Research Infrastructure Award. (See RFA-OB-03-004,
Mind-Body Interactions and Health: Research Infrastructure Program.)
Find Funding Opportunities
COVID-19 Funding Notices | Approved Initiative Concepts | Research Opportunity Announcements
All NINDS-related notices of funding opportunities (NOFOs), request for applications (RFAs), program announcements (PAs), and other NIH Guide announcements are listed. Search the Closed Opportunities tab to find expired opportunities. Search the Notices tab to find all Notices.
Learn more about award types and program directors and managers.
NINDS has a number of open positions for researchers and clinicians to contribute to exciting neuroscience programs - APPLY NOW!
For more focused results add quotes to indicate parameters. Example format: "search term".
Expiration Date: Thursday, July 17, 2003 NOFO Number: RFA-OB-03-005 Release Date: Thursday, January 9, 2003 Notice Type: RFA
Expiration Date: Wednesday, June 11, 2003 NOFO Number: RFA-TW-03-003 Release Date: Thursday, January 9, 2003 Notice Type: RFA
The International Clinical, Operational, and Health Services Research
Training Award for AIDS and Tuberculosis (ICOHRTA-AIDS/TB) Program provides
extended support for training to foster collaborative, multidisciplinary
research in developing country sites where HIV/AIDS, tuberculosis (TB) or
both are significant problems. As used in this Request for Applications
(RFA), the term ICOHRTA-AIDS/TB is broadly defined to encompass building
capacity for integrated clinical, operational, and health services research
across the full range of conditions and issues that relate to care of adult
and pediatric patients with HIV/AIDS or TB (e.g., opportunistic infections,
HIV malignancies, neurological and mental health consequences, behavioral
issues, cardiovascular disease, hematologic conditions, blood safety issues,
pulmonary manifestations, ophthalmologic manifestations, gastrointestinal
conditions, drug and alcohol usage, gender-related issues and oral health
manifestations). This program is an integral and critical component of a
comprehensive global strategy of the National Institutes of Health (NIH) and
Department of Health and Human Services (DHHS) to address the needs of the
millions suffering from HIV/AIDS, TB, and related conditions in resource-
limited nations. It will extend and intensify efforts to provide clinically
appropriate and sustainable care to these individuals in a manner that
supports continuing and expanding prevention activities. These efforts will
have direct health, economic and security benefits for the United States
(U.S.), as well as the global community. This program will increase research
training across the span of clinical science and public health practice and
involve a wide range of health professionals (e.g. nurses, midwives,
physicians, dentists, health care administrators and public health workers).
The first phase of the ICOHRTA-AIDS/TB program began in fiscal year 2002
(FY02), with one-year planning grants (PA-02-022) to foreign institutions to
organize and execute an application for a Phase II Comprehensive ICOHRTA-
AIDS/TB Cooperative Agreement. Only the recipients of the Phase I planning
grants and their chosen U.S. (or pre-approved non-U.S) collaborating partner
institutions (together referred to as Research Training Units) are eligible
to apply for Phase II Comprehensive ICOHRTA-AIDS/TB awards, which will begin
in fiscal year 2004 (FY04). The Phase II awards to the Research Training
Units will provide support to both the foreign institution and its linked
U.S. partner (or pre-approved non-U.S.) institution through five-year
cooperative agreements to each partner institution. Each partner institution
will be responsible for implementation of its portion of the integrated
research-training program. Training will take place at the U.S. or foreign
sites and mentored research will be carried out mainly at the foreign site.
The program may also provide support at the foreign site for training to
develop and extend core research support capabilities necessary for long-term
sustainability of the research capacity of the foreign institution. In
support of the overall ICOHRTA-AIDS/TB program, a separate RFA will be issued
in fiscal year 2003 (FY03) to fund a single Coordination Center in FY04 which
will help to monitor and evaluate the ICOHRTA-AIDS/TB program research
training units and to develop programs to address common capacity building
needs across the research training.
The Fogarty International Center (FIC), together with the National Institute
on Alcohol Abuse and Alcoholism (NIAAA), the National Institute of Allergy
and Infectious Diseases (NIAID),the National Institute of Child Health and
Human Development (NICHD), the National Institute on Drug Abuse (NIDA), the
National Institute of Mental Health (NIMH), the National Institute of
Neurological Disorders and Stroke (NINDS), the Office of Research on Women's
Health (ORWH), the Centers for Disease Control and Prevention (CDC), and the
United States Agency for International Development (USAID), invites Phase I
awardees to submit applications for Phase II cooperative agreements to
develop comprehensive international clinical, operational, and health
services research training programs. These applications should foster the
development of integrated strategies to successfully implement evidence-based
interventions pertinent to the global health crises created by HIV/AIDS and
TB. Co-sponsoring institutions are U.S. Government (USG) agencies
contributing financial resources to the ICOHRTA-AIDS/TB Program. Applicants
are strongly encouraged to design programs that strengthen the capacity of
the foreign institutions to collaborate with the NIH, USG, other governments,
international agencies, non-governmental organizations, foundations, faith-
based organizations and other groups in their efforts to respond to this
global health crisis.
Expiration Date: Friday, December 16, 2005 NOFO Number: PAR-03-051 Release Date: Tuesday, January 7, 2003 Notice Type: PAR
This PA replaces PAR-01-118
The NINDS seeks to fund high quality clinical trials to evaluate treatments
for neurological disorders. The purpose of the NINDS Clinical Trial Planning
Grant is to provide support for the organization of activities critical for
the successful implementation of high-risk, complex, or large-scale clinical
trials. The planning grant is intended to (a) allow for early peer review
for the rationale and design of the proposed clinical trial; (b) provide
support for the development of a detailed manual of operations and
procedures; and (c) provide support to develop essential elements of a
clinical trial, such as adequate plans for recruitment of patients,
experimental design and protocols, data management, analytical techniques,
facilities, administrative procedures, obtaining IND/IDE, and collaborative
arrangements. The purpose of the NINDS planning grant is not to obtain
preliminary data or to conduct pilot studies to support the rationale for the
clinical trial.
Expiration Date: Thursday, March 13, 2003 NOFO Number: RFA-AG-03-005 Release Date: Thursday, December 19, 2002 Notice Type: RFA
The purpose of this RFA is to facilitate collaborative cross-
disciplinary and multi-institutional approaches that will contribute
new and vital information about the clinical and pathological course of
normal aging and the neurodegenerative diseases associated with aging.
This RFA requires the utilization of data and/or samples from at least
three currently funded NIA Alzheimer's Disease Centers with the
possibility of using additional relevant data outside of the Centers.
The project should use the National Alzheimer's Coordinating Center
(NACC) http://www.alz.washington.edu/ for expert advice on planning,
study design, statistical analysis and data management of the research
projects. Applicants can be from the Alzheimer's Disease Centers, the
Morris K. Udall Centers, or the research community at large. There must
be a plan to share data originating from these studies by archiving
them at NACC so that other investigators will be able to conduct
additional analyses when appropriate. There must also be a plan for
sample utilization beyond that of the initial application.
This is a research opportunity for scientists within and outside the
Alzheimer's Disease Centers to gain access to unique resources related
to Alzheimer's Disease, other neurodegenerative diseases, and normal
aging and to support collection of new data and samples. Applicants can
also propose to utilize Center data and samples to investigate other
age-related neurodegenerative diseases, such as Vascular dementia,
Parkinson's dementia, Lewy Body disease, Fronto-Temporal dementia, as
well as study psychiatric symptoms associated with dementia, socio
behavioral aspects of dementia, and management and care of dementia
patients.
The National Institute of Neurological Disorders and Stroke (NINDS) is
interested in those specific applications which include the Morris K.
Udall Centers of Excellence, or other Parkinson's research centers, in
the pursuit of those research objectives focused on Parkinson's Disease
(PD) or related parkinsonisms. The PD center need not be located with
ADCs, but collaboration with those ADCs with existing samples and data
sets focused on PD is required. Specific scientific projects of
interest include the use of clinico-pathological correlations to study
mechanisms of pathogenesis in PD or other parkinsonian conditions,
characterization of the pathological features of these conditions, and
the collection of patient data on their associated symptoms.
Expiration Date: Saturday, August 19, 2006 NOFO Number: PAR-03-045 Release Date: Thursday, December 12, 2002 Notice Type: PAR
This Program Announcement (PA), issued as an initiative of the trans-
NIH Bioengineering Consortium (BECON), is aimed at enhancing
nanoscience and nanotechnology research approaches that have the
potential to make valuable contributions to biology and medicine.
Nanoscience and nanotechnology refer to research at the atomic,
molecular or macromolecular levels, at the length scale of
approximately 1 - 100 nanometers. The purpose of this initiative is to
stimulate cross-cutting, integrative research in these fields of
science and technology. In particular, this initiative invites research
on: i) the creation and use of structures, devices and systems that
have novel properties and functions because of their small size, that
may be used to achieve a fundamental understanding of biological
processes and /or contribute to disease detection, therapy, or
prevention; ii) conception and fabrication of devices, that will
effectively detect and analyze nanoscale entities of relevance to
biomedicine; and iii) the study of biological systems at the nanoscale
for the explicit purpose of using that information to develop
nanotechnologies and nanostructured materials that will in turn benefit
biology and medicine.
It is anticipated that the research projects that will be most
responsive to this PA will require interdisciplinary collaborations
among investigators with expertise in a range of disciplines, including
but not limited to engineering, physics, chemistry, cellular and
molecular biology, materials and computer science. Applications
submitted in response to this PA may propose hypothesis-driven,
discovery-driven, developmental, or design-directed research.
Expiration Date: Friday, September 23, 2005 NOFO Number: PAR-03-035 Release Date: Tuesday, December 3, 2002 Notice Type: PAR
The purpose of this initiative is to encourage and support investigator-
initiated research on neuroscience informatics (neuroinformatics). This
research will lead to the development of new web based databases, analytical
tools, and knowledge management systems to foster sharing of data for all
domains of neuroscience research. This program combines neuroscience and
informatics (neuroinformatics) research to develop and apply advanced tools and
approaches essential for efficient understanding of the structure, function and
development in health and disorders of the nervous system, from the genetic to
whole systems level. Research in informatics includes databases, graphical
interfaces, querying approaches, information retrieval, data visualization and
manipulation, and data integration through the development of integrated
analytical tools, synthesis, and tools for electronic collaboration. In order
for these advanced information technologies to be put to wide use by the
neuroscience community, they should be generalizable, scalable, extensible, and
interoperable, and be developed in concert with significant neuroscience
research.
Expiration Date: Saturday, February 22, 2003 NOFO Number: RFA-DK-03-012 Release Date: Tuesday, November 26, 2002 Notice Type: RFA
The Division of Kidney, Urologic, and Hematologic Diseases (DKUHD) of
the National Institute of Diabetes and Digestive and Kidney Diseases
(NIDDK), in collaboration with the National Institute of Neurological
Disorders and Stroke (NINDS) and the National Institute of Child Health
and Human Development (NICHD), invites cooperative agreement
applications for two Clinical Coordinating Centers and a Data
Coordinating Center to conduct a prospective epidemiological study of
children with chronic kidney disease. The primary goals of this study
are to determine the risk factors for decline in renal function; the
incidence of, and risk factors for, impaired neurocognitive development
and function; the prevalence of risk factors for cardiovascular
disease; and the long-term effects of growth failure and its treatment.
Expiration Date: Sunday, August 24, 2003 NOFO Number: PAR-03-032 Release Date: Wednesday, November 20, 2002 Notice Type: PAR
Participating Institutes and Centers (ICs) of the National Institutes of
Health (NIH) invite applications for R01 awards to support Bioengineering
Research Partnerships (BRPs) for basic and applied multi-disciplinary research
that addresses important biological or medical research problems. A BRP is a
multi-disciplinary research team applying an integrative, systems approach to
develop knowledge and/or methods to prevent, detect, diagnose, or treat
disease or to understand health and behavior. The partnership must include
appropriate bioengineering or allied quantitative sciences in combination with
biomedical and/or clinical investigators. A BRP may propose design-directed,
developmental, discovery-driven, or hypothesis-driven research at
universities, national laboratories, medical schools, large or small
businesses, or other public and private entities or combinations of these
entities.
On October 11, 2001, NIH issued a related program announcement (PA) PA-02-011
for Bioengineering Research Grants (BRGs). The BRGs differ from the BRPs in
that the BRG research will be performed in a single laboratory or by a small
number of investigators.
Expiration Date: Tuesday, November 1, 2005 NOFO Number: PA-03-031 Release Date: Monday, November 18, 2002 Notice Type: PA
The National Institute of Biomedical Imaging and Bioengineering (NIBIB), the
National Heart, Lung, and Blood Institute (NHLBI), the National Institute of
Environmental Health Sciences (NIEHS), the National Center for Research
Resources (NCRR), the National Institute of Diabetes and Digestive and Kidney
Diseases (NIDDK), and the National Institute of Neurological Disorders and
Stroke (NINDS) invite grant applications for Small Business Innovation
Research (SBIR) and Small Business Technology Transfer (STTR) awards to
support research and development of small animal imaging devices and methods
that can be applied broadly to research on diverse biological or disease
processes. A similar Request for Applications (RFA) for small animal imaging
research and development to be supported by individual Research Project Grant
(R01) awards can be found at
(http://grants.nih.gov/grants/guide/rfa-files/RFA-EB-03-002.html).
The primary focus of this Program Announcement (PA) is research and
development related to devices, methods, and imaging agents for the
investigation of biological and disease processes in small animals. The
integration of systems and methods with complementary imaging and/or
spectroscopy modalities is also included as appropriate to provide anatomic,
physiologic, metabolic, and molecular-level information in small animal
models of disease.
The motivation for this PA is that recent discoveries in genomics and
molecular and cell biology have led to the development and wide use of small
animal models of human disease. One of the limitations with the use of these
models is the need to sacrifice large numbers of animals for ex vivo tissue
and molecular analysis. Imaging instrumentation and methods that permit
imaging on the scale of small animals offer an opportunity to address this
problem by enabling noninvasive investigations of biological processes in
vivo. This capability provides the potential for longitudinal studies in the
same animal. The coupling of animal models of human disease with advances in
imaging technology presents an extraordinary opportunity for biomedical
imaging to play an important role in the early detection, diagnosis, and
treatment of disease. Several dedicated small animal imaging systems have
been developed and a few commercialized, although technological hurdles still
exist that limit the realization of the full potential of small animal
imaging for biomedical research and drug development. Progress is needed to
improve throughput, sensitivity, and spatial and temporal resolution of small
animal imaging devices, to provide quantitative information through improved
reconstruction methods that incorporate models of physical effects, and to
provide improved methods for system validation. System optimization
incorporating the design of molecular probes that serve as links to
particular biological processes in vivo is also a focus. Further improvements
in system design, image processing and analysis software, and data sharing
technology, coupled with improvements and innovations in animal handling
techniques during imaging, are needed to make small animal imaging technology
more accessible to molecular biologists and pharmaceutical scientists
desiring to use animal models as tools for biomedical research and drug
discovery and development.
Expiration Date: Wednesday, March 12, 2003 NOFO Number: RFA-TW-03-007 Release Date: Thursday, November 7, 2002 Notice Type: RFA
This Request for Applications (RFA) solicits applications to plan and develop
collaborative research and capacity building projects on brain disorders
throughout life relevant to low- and middle-income nations. Applicants are
expected to develop innovative, collaborative research programs that would
contribute to the long-term goal of building sustainable research capacity in
neurological/neurodevelopmental (including sensory, motor, cognitive and
behavioral) impairment throughout life.
This RFA is joined by the following Institutes and Centers: NIH sponsors
include the Fogarty International Center (FIC), National Eye Institute (NEI),
National Institute on Aging (NIA), National Institute on Alcohol Abuse and
Alcoholism (NIAAA), National Institute of Child Health and Human Development
(NICHD), National Institute on Drug Abuse (NIDA), National Institute of
Environmental Health Sciences (NIEHS), National Institute of Mental Health
(NIMH), National Institute of Neurological Disorders and Stroke (NINDS) and
the Office of Dietary Supplements (ODS); for Canada, the Canadian Institutes
of Health Research (CIHR) and for Mexico, the Consejo Nacional de Ciencia y
Tecnologa (Conacyt). These sponsoring organizations seek domestic and
international collaborative applications which address brain disorders in the
developing world and which build research capacity of low- to middle-income
countries to address brain disorders within their country or region.
This first phase of the "Brain Disorders in The Developing World: Research
Across the Lifespan" initiative, beginning in fiscal year 2003 (FY03), will
consist of two-year planning/development grants using the R21 grant
mechanism. The R21 grant will provide support to initiate preliminary
studies and to organize, plan, prepare, and assemble an application for a
more comprehensive R01 grant involving collaboration between high-income and
low- to middle-income country investigators and which incorporates both
research and capacity building.
The main goals of the R21 applications should be to assess needs, develop
collaborations and needed resources, show feasibility and generate
preliminary data for the collaborative research to be proposed in a follow-up
R01 submission. The applicants should propose specific milestones and a
timeline to meet these goals. During the R21 award period, the applicant
should:
o further define the type and area of research to be developed;
o develop and solidify collaborative relationships and understandings with
the partners in the developed and developing countries involved;
o assess current resources and needs, such as and including the need for an
institutional review board (IRB) for studies involving human subjects;
o develop and initiate a plan to address these needs to enable the proposed
research and capacity building to be successfully carried out;
o identify the training and other capacity-building opportunities to be
incorporated into the research application in the context of the proposed
research;
o initiate cross-training of collaborators where necessary for the proposed
research; and
o conduct pilot studies and generate preliminary data;
Projects should: 1) Involve a partnership between high-income and low-to
middle-income country individuals or research teams; 2) lead to pursuit of
basic, epidemiological, clinical, prevention, intervention or health services
research in the area of brain disorders of relevance to low- to middle-income
countries; and 3) build capacity as necessary in the proposed research area
to enable further research to take place.
An RFA for the second competitive phase of the "Brain Disorders in The
Developing World: Research Across the Lifespan" initiative is currently
planned to be issued in fiscal year 2005 (FY05), subject to availability of
funds. That RFA is planned to provide support for collaborative research and
capacity building to high-income and low- to middle-income country partners
through the R01 mechanism. The second phase RFA competition, as currently
planned, will not be limited to the R21 grantees under this competition, but
will be open to all eligible applicants.